Faron patents Traumakinen for a new formulation. The company has received orphan drug status (Orpan Dru.) In the EU for the ARDS indication. Traumaki cannot have any competitors in the EU Within 10 years of the issuance of the permit. Legislation protects .values medication. Time ... ticking and see the moon. TRANSLATED WITH GOOGLE